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Background.  Epilepsy is highly prevalent in people with intellectual disabilities and is associated with 
increased mortality and high healthcare usage.  This systematic review summarises research on 
service responses to people with intellectual disabilities and epilepsy.  
Method.  Studies published from 1990 were identified via electronic searches using Medline, Cinahl, 
PsycINFO and Web of Science, email requests to researcher networks, and cross-citations. 
Information extracted from studies was reviewed narratively in relation to identified themes. 
Results.  35 studies  met the inclusion criteria. Overall study quality was low, with no RCTs or 
similarly robust intervention study designs.  Access to specialists was inconsistent.  The importance 
of proxies and the need for education regarding epilepsy for staff, carers and people with intellectual 
disabilities was highlighted.      
Conclusion.  There are no methodologically robust studies on service related interventions for 
people with intellectual disabilities and epilepsy.  Further research on improving service delivery is 
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Epilepsy is one of the most common serious brain disorders, affecting over 50 million people 
worldwide (WHO, 2005), approximately 0.5% to 1.0% of the general population (Forsgren et al., 
2005, Linehan et al., 2010, Joint Epilepsy Council, 2011).  Despite variations in reported prevalence 
figures, the prevalence of epilepsy in people with intellectual disabilities is clearly much greater than 
in the general population.  A systematic review and meta-analysis of 38 studies of general samples of 
people with intellectual disabilities found a pooled prevalence of 22.2% (95% CI 19.6, 25.1)  
(Robertson et al., 2015b).   
 
Epilepsy is associated with increased mortality in people with intellectual disabilities, particularly in 
those experiencing recent seizures (Robertson et al., 2015a).  For people with intellectual disabilities, 
epilepsy or convulsions has been identified as an important and to some extent preventable cause of 
death (Glover and Ayub, 2010).  Based on Standardised Mortality Odds Ratios (SMORs), adjusting for 
ages at death, people where death involved epilepsy or unspecified convulsions were 9.7 times more 
likely than others to have an intellectual disability-related condition (95% confidence interval 9.1, 
10.4).   
 
There is little information available on the costs of epilepsy specifically for people with intellectual 
disabilities.  One study examined the health and social care costs of supporting 91 adults with active 
epilepsy and intellectual disabilities living in the community in England (Pennington et al., 2012).  
Costs of health and social services of supporting people with epilepsy and intellectual disabilities 
were found to be high, but epilepsy related health care costs were a small fraction of overall costs, 
with most being primarily due to the cost of providing appropriate accommodation and living 
support and appropriate activities for people with intellectual disabilities.  The study suggests that 
the costs of epilepsy management are higher for people with intellectual disabilities than for the rest 




of the population.   Epilepsy has also been found to be associated with additional costs in an 
institutional setting in the United States (Burke et al., 1999).   
 
It is clear that people with intellectual disabilities and epilepsy have high health care usage.  In the 
Dutch National Survey of General Practice, the most frequently presented health problem in people 
with intellectual disabilities in primary care settings was epilepsy (Straetmans et al., 2007).  Patients 
with intellectual disability and co-existing epilepsy in Wales also used secondary care services 
(inpatients, outpatients, and accident and emergency (A&E)) more frequently than those with 
intellectual disability only (Morgan et al., 2003).  In England, it has been reported that ‘convulsions 
and epilepsy’ accounted for more than 40% of all emergency admissions for ambulatory care 
sensitive conditions (ACSCs) for people with intellectual disabilities, accounting for 6,000 admissions 
and 28,000 bed days per year (Glover and Evison, 2013).  Similarly, a Canadian study found that for 
people with intellectual disabilities, 27% of admissions for ACSCs were for epilepsy, a hospitalisation 
rate 54 times higher than for people without intellectual disabilities (Balogh et al., 2010).    
 
Given the high prevalence of epilepsy in people with intellectual disabilities, the associated 
increased mortality, and high health care usage, the issue of how services should respond to epilepsy 
in people with intellectual disabilities is important.  The management of epilepsy in people with 
intellectual disabilities presents unique challenges, such as the possibility of misdiagnosis due to the 
misinterpretation of behavioural, physiological, syndrome related, medication related or 
psychological events by parents, paid carers and health professionals (Chapman et al., 2011).   
Clinical guidelines relating to the management of epilepsy in people with intellectual disabilities are 
available.  The National Institute for Health and Clinical Excellence include a section on children, 
young people and adults with intellectual disabilities in their clinical guidelines for the diagnosis and 
management of the epilepsies in adults and children in primary and secondary care (National 
Institute for Health and Care Excellence, 2012), with the Guideline Development Group stating that 




“this patient group has traditionally received sub-optimal care, and less access to specialist epilepsy 
services” (National Clinical Guideline Centre, 2012, p552). Consensus guidelines into the 
management of epilepsy in adults with an intellectual disability have been produced using a 
modified Delphi method by the International Association for the Scientific Study of Intellectual and 
Developmental Disabilities (IASSIDD) (Kerr et al., 2009).  International consensus clinical practice 
statements have also been developed regarding the treatment of neuropsychiatric conditions 
associated with epilepsy (Kerr et al., 2011).  Finally, earlier guidelines produced by IASSIDD  include 
recommendations relating to the care context and has a specific section on standards for services 
(Kerr et al., 2001). 
 
For people with epilepsy generally, research on service approaches is evident.  For example, a 
Cochrane review on care delivery and self-management strategies for adults with epilepsy (Bradley 
Peter and Lindsay, 2008)  identified 13 trials and 16 reports, including five trials of specialist epilepsy 
nurses.  There was some evidence of benefit for interventions based on specialist epilepsy nurses 
and self-management education.  Since this review was conducted, further research has been 
conducted such as a non-randomised trial of a nurse led self-management intervention to reduce 
emergency visits by people with epilepsy (Noble et al., 2014) and further research regarding self-
management education is ongoing (Magill et al., 2015).  However, an earlier literature review found 
no research in the area of service delivery for people with intellectual disabilities and epilepsy  
(Bowley and Kerr, 2000).    
 
This review aims to identify and summarise research on service responses to the general population 
of people with intellectual disabilities and epilepsy and as such it excludes studies on specific 
syndromes associated with intellectual disabilities.    The effectiveness of either pharmacological or 
non-pharmacological treatments for epilepsy in people with intellectual disabilities are not covered 
for two reasons. First, recent Cochrane reviews exist (Beavis et al., 2007a, Beavis et al., 2007b; both 




assessed as up to date in 2011), as well as a protocol for a future Cochrane review of 
pharmacological and non-pharmacological interventions for epilepsy in people with Down syndrome 
(Bashir et al., 2013).    Second, NICE (2012) guidelines state that:  “The recommendations on choice 
of treatment and the importance of regular monitoring of effectiveness and tolerability are the same 
for those with learning disabilities as for the general population” (National Institute for Health and 
Care Excellence, 2012, p51).  However, the review does include the use of rescue medication due to 
the impact service factors, such as training of staff or carers in its use, may have on outcomes.   The 
review aims to cover research on a disparate range of topics within the broad area of service 
responses to epilepsy in people with intellectual disabilities published from 1990 onwards.   
 
Method 
Electronic literature database searches were conducted in Medline, Cinahl and PsycINFO (all on 
EBSCO) and Web of Science (SCI-EXPANDED, SSCI and A&HCI).  Searches were also conducted in the 
following clinical trials registers: Cochrane Central Register of Controlled Trials (CENTRAL); 
ClinicalTrials.gov (U.S. National Institutes of Health); ISRCTN registry; and the UK Clinical Trials 
Gateway.  The reference lists of articles meeting the inclusion criteria were searched and articles 
from authors’ personal collections included.  A request for information on research relevant to the 
review was sent in January 2015 to the membership of the International Association for the 
Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) Health Special Interest 
Research Group and the Intellectual Disability UK Research mailing list.   
 
Searches combined word and index terms for epilepsy, intellectual disabilities, and service responses 
with the Boolean operator ‘and’.   During the process of producing earlier reviews regarding people 
with intellectual disabilities who have epilepsy (Robertson et al., 2015b, Robertson et al., 2015a), 
research articles relevant to any aspect of service responses were identified and word search terms 
were developed based on these. Where available, each database index was also explored to identify 




index terms relevant to service responses and these were combined with word search terms using 
the Boolean operator ‘or’.  Searches were completed in January 2015.  Full details of the search 
terms are given in Appendix One.   
Inclusion Criteria 
Articles were required to meet all following criteria: 
 Peer reviewed 
 English language full text 
 Published from 1990 
 Primary research, service audit or evaluation    
 Samples of people with intellectual disabilities or samples where 50% or more have 
intellectual disabilities or mixed samples where results are disaggregated for people with 
intellectual disabilities 
In addition, articles had to meet one of the following criteria: 
 Studies of interventions aiming to improve knowledge or practice in relation to service 
responses to people with intellectual disabilities and epilepsy; or 
 Studies of current knowledge or practice in relation to service responses to people with 
intellectual disabilities and epilepsy; or 
 Studies on opinions of professionals, carers or family with regard to services for people with 
intellectual disabilities and epilepsy; or 
  Studies considering service related factors associated with outcomes for people with 
intellectual disabilities and epilepsy. 
 
Exclusion Criteria 
 Not peer reviewed or where peer review status was unclear 
 Letters, commentaries, editorials, meeting or conference abstracts 
 Case studies or case series 




 Only includes information relating to specific syndromes eg. Dravet syndrome 
 Narrative reviews 
 Conditions where intellectual disabilities cannot be assumed (e.g. cerebral palsy, autistic 
spectrum disorder (ASD)) where results not disaggregated for people with intellectual 
disabilities 
 Pharmacological or non-pharmacological treatment of epilepsy, except studies relating to 
the use of rescue medications by family or paid caregivers. 
 
Initially, titles and abstracts were used to exclude articles obviously not within the scope of the 
review (1st and 2nd author).   Those retained for further screening were those for which relevance 
could not be assessed without accessing full text, or those that were chosen as potentially within 
scope. These studies were screened by two authors (1st and 4th author) and discussed until 
consensus was reached on whether or not they met the inclusion criteria.   
 
It was evident from the outset that there were no randomised controlled trials (RCTs) or studies with 
robust research designs and as such formal quality assessment of the literature identified was not 
undertaken.  All relevant studies were included in the review regardless of methodological quality, 
although studies were categorised by research design in order to illustrate the overall number of 
studies identified in relation to established hierarchies of evidence (GRADE Working Group, 2004).   
 
Data Extraction & Synthesis 
Data were extracted from the full text of included articles. Textual descriptions were produced for 
each study by the 1st author.  This included: bibliographic details; the country within which the study 
took place; details of the focus of the study; sample size and characteristics; study design and data 
sources; measures employed; main results; and issues raised in the discussion.   This information 
was then tabulated.   





The tabulated descriptions were reviewed by the 1st author to identify themes emerging from the 
literature for inclusion in the review results.  An iterative approach was taken to determining themes 
with topics being listed as they arose and theme headings being developed which best categorised 
the topics.  The 4th author also reviewed the tabulated descriptions of the studies in order to assess 
the appropriateness of the identified themes and no disagreement occurred.   Studies providing 
evidence in relation to each theme were then identified from the textual descriptions and the 
information reviewed narratively .  It was generally not possible to compare results between studies 
directly due to variation in the methods used. As such, no meta-analysis was conducted.   
 
Results 
The process of identifying studies for inclusion is summarised in Figure One.  Electronic database 
searches identified 1,861 references, with 1,481 remaining after removal of 380 duplicates. 
Following the first screening, 1,333 references were excluded and 148 remained for further 
screening.  After examination of full text articles and the addition of articles cited within these and 
from authors’ personal collections, 35 articles met the criteria for inclusion.  Searches of clinical trials 
registers identified 135 records of which 2 were relevant ongoing trials where results were not yet 
available (Durand et al., 2014, Ring et al., 2014) and these trials are considered further in the 





Most studies identified were from the United Kingdom, including 17 from England (Ahmad et al., 
2007, Beber et al., 1999, Branford and Collacott, 1994, Branford et al., 1998, Cole et al., 2009, 
Deepak et al., 2012, Esan and Markar, 2010, Frost et al., 2003, Kiani et al., 2014, Markar and 




Mahadeshwar, 1998, Mobbs et al., 2002, Mukhopadhyay et al., 2010, Redley et al., 2013, Reuber et 
al., 2008, Ring et al., 2009, Tiffin and Perini, 2001, Whitten and Griffiths, 2007),  three from Wales 
(Chubb et al., 1995, Matthews et al., 2008, Morgan et al., 2003), and one from Scotland (Clark et al., 
2001).    There were four studies from the United States (Baribeault, 1996, Buelow et al., 2006, Hom 
et al., 2015, Litzinger et al., 1993) and in one survey most respondents were from the United States 
(US) (Camfield et al., 2011).  There were also two studies from Australia (Beran and McAulley, 1992, 
Kyrkou et al., 2006), two from the Netherlands (Vallenga et al., 2006, Vallenga et al., 2008) and one 
each from Belgium (Peeters, 2000), Canada (Fridhandler et al., 2012), and Ireland (McCarron et al., 
2014).  One further study included both the UK and Ireland (Thompson et al., 2013).  Finally, an 
international online survey obtained responses from 14 countries although most responses were 
from the UK (Kerr et al., 2014).  There were no studies identified from low or middle income 
countries (LAMI). 
 
Table One Here: Summary of Studies 
Study Designs 
No RCTs or other intervention studies with robust designs were identified.   There were no matched 
comparison groups and no study used randomization.  There were: 12 articles based on cross-
sectional quantitative survey methods (Cole et al., 2009, McCarron et al., 2014, Branford et al., 1998, 
Beran and McAulley, 1992, Frost et al., 2003, Mobbs et al., 2002, Reuber et al., 2008, Branford and 
Collacott, 1994, Camfield et al., 2011, Kyrkou et al., 2006, Mukhopadhyay et al., 2010, Deepak et al., 
2012); six articles based on qualitative methods (Vallenga et al., 2006, Vallenga et al., 2008, Buelow 
et al., 2006, Redley et al., 2013, Thompson et al., 2013, Kerr et al., 2014); and five articles based on 
audits (Chubb et al., 1995, Esan and Markar, 2010, Markar and Mahadeshwar, 1998, Tiffin and 
Perini, 2001, Whitten and Griffiths, 2007).   One article was based on description of clinical 
experience (Baribeault, 1996).  One cross-sectional prevalence study was identified which contained 
information related to service and antiepileptic drug (AED) receipt (Matthews et al., 2008). There 




were three articles based on retrospective review of varied data sources (Fridhandler et al., 2012, 
Hom et al., 2015, Kiani et al., 2014) and one combined retrospective review of data sources with 
interviews (Ring et al., 2009).  One used record linkage to obtain standardized activity ratios for 
health service use (Morgan et al., 2003).     
 
Whilst a small number of studies looked at outcomes prior to and following a service intervention, 
some did not employ a comparison group (Litzinger et al., 1993, Ahmad et al., 2007).  One study on 
the use of a decision tree for responding to seizures compared data from a prospective study of its 
use of with retrospective data prior to its use (Peeters, 2000).    One study on the use of an 
educational package for people with mild intellectual disabilities used a deferred treatment group as 
a comparison group (Clark et al., 2001).   One study on the establishment of an intellectual 
disabilities psychiatric service compared baseline and outcome measurements for those who did  
compared to those who did not receive psychiatric care (Beber et al., 1999).    
 
Themes identified in relation to service responses to epilepsy in people with intellectual disabilities 
In the following sections, we present a narrative summary of information identified in the 35 studies 
in relation to specific themes: service provision/configuration; the impact of service setting; epilepsy 
reviews; epilepsy care plans; investigations; seizure diaries; medication adherence; management by 
proxy; risk assessment; managing prolonged or serial seizures (rescue medication); educating people 
with intellectual disabilities about their epilepsy; evaluations of initiatives in services; prescribing 
practices; and views of families, carers or professionals regarding services.  Further details on the 
studies can be found in Table One.   
 
Service Provision/Configuration 
Within the UK, the management of epilepsy for people with intellectual disabilities has been 
provided by various combinations of primary care, specialist epilepsy and neurology services as well 




as intellectual disability mental health services and social care agencies (Ring et al., 2009).   This 
section summarises information regarding patterns of service provision.   
In one English county, 37% of those with intellectual disabilities and epilepsy received epilepsy care 
from a hospital-based neurology service (Ring et al., 2009). The patients’ GP also actively contributed 
to their epilepsy care, in terms of initiating or changing treatments, in 63% of cases and for 6% of 
participants the GP was the only clinician supporting epilepsy treatment.   It was not clear what 
determined which treatment pathway individual patients followed.  Obvious factors, such as 
markers of epilepsy severity or associated co-morbidities, did not appear to play a role (Ring et al., 
2009).  However, the picture may be different in other areas.  For example, in a study on the 
establishment of an intellectual disabilities psychiatric service in one English county after a five year 
period without one, it was noted that at baseline most received GP care only for their epilepsy 
(Beber et al., 1999).   
 
Further evidence points to a lack of comprehensive involvement by specialist services for those with 
intellectual disabilities and epilepsy.  In one English county, the specialist intellectual disability 
service had no involvement for 29% of those in the community receiving AEDs (Branford and 
Collacott, 1994).  In an English city, 60.6% of patients with ongoing seizures, 57.9% with major 
seizures and 68.7% of individuals taken to hospital with prolonged seizures had no access to 
specialist advice (Reuber et al., 2008).  A prevalence study in Wales found that for those with 
intellectual disabilities and epilepsy, slightly over one in four participants had not seen a specialist 
(Matthews et al., 2008).    
 
Matthews et al (2008) suggest that lack of specialist input may reflect a failure of continuity of care 
from paediatric to adult services.  In a survey of predominantly pediatric neurologists from the US, 
lack of an adult neurologist willing to care for adults with epilepsy and an intellectual disability was 
noted by 35% to be a barrier to transitioning a patient to adult care (Camfield et al., 2011).   





Further studies point to a lack of dedicated or specialist services.  A survey of 215 health 
professionals in England regarding epilepsy care found that less than one third had a dedicated clinic 
for people with intellectual disabilities (Frost et al., 2003).  A survey regarding how community 
learning disability nurses (CNLDs) work within National Health Service (NHS) trusts in England found 
that 25 (23%) had CNLDs specializing in epilepsy (Mobbs et al., 2002).  In a study of professionals and 
carers from the UK and Ireland, respondents stated that specialist expertise was available regionally 
only if consultants had a specific interest in the intellectual disability field (Thompson et al., 2013). 
This geographical distribution of expertise is termed a ‘postcode lottery’ within the UK.  The role of 
specialist nurses was favourably regarded, with a call that more of these posts were required to 
meet need.  One study found that 34% of people with intellectual disabilities and epilepsy had seen 
an epilepsy nurse (Reuber et al., 2008).   
 
The impact of service setting 
A small number of studies present information indicating that elements of service provision may 
have an impact on some outcomes for people with intellectual disabilities and epilepsy.  In the US, 
living situation was found to be associated with adherence to AEDs, with non-adherence being 6% in 
group homes, 20% in semi-independent living, and 32% in family homes (Hom et al., 2015).  In 
Ireland, those in residential care were more likely to have a seizure diary (93%) than those living 
independently (44%) or in the community (78%) (McCarron et al., 2014).    A study in an English 
county found an association between polypharmacy and the degree of involvement of specialist 
intellectual disability services (Branford and Collacott, 1994).  Further, those in the NHS were more 
likely to receive carbamazepine and those outside NHS more likely to receive phenytoin, 
phenobarbitone and primidone.  In Wales, it was found that institutionalized individuals with 
intellectual disabilities and epilepsy had less inpatient, outpatient, and A&E admissions compared to 
those in the community (Morgan et al., 2003).  It is suggested that this may be because many of 




their health needs are dealt with within the institution or there is a greater threshold before an 
event is deemed as requiring an acute admission.   
 
Epilepsy Reviews 
In an English city, 70.7% of those with intellectual disabilities and epilepsy were reported to have 
had an epilepsy treatment review within the last 12 months (Reuber et al., 2008).  Overall, 38.7% 
were reported to be under review in secondary care (neurologist, psychiatrist or epilepsy nurse), 
52.9% stated that reviews were carried out in primary care alone and 8.9% said that epilepsy 
treatment had not been reviewed at all (Reuber et al., 2008).  In a sample of 229 people aged 40 or 
more with intellectual disability and epilepsy from Ireland, 80.8% had had an epilepsy review within 
the past 12 months, 5.1% within the past 2 years,  11.6% over 2 years ago, and 2.5% had never had 
their epilepsy reviewed (McCarron et al., 2014).  In this study, 51% reported that a GP reviewed their 
epilepsy, 40% a psychiatrist, 42% a neurologist and 34.7% more than one group/professional. 
 
Epilepsy Care Plans 
There is very little research regarding the use of epilepsy care plans.  A study in England examined 
the case notes of 20 people with intellectual disabilities who had died from SUDEP of whom 65% had 
an Epilepsy Care Plan (Kiani et al., 2014).  In a survey on the use of rescue medication 84 (60%) 
participants had an epilepsy care plan (Mukhopadhyay et al., 2010). 
 
Investigations 
A national audit into SUDEP highlighted poor access to investigation for those with intellectual 
disabilities (Hanna et al., 2002).  In a Welsh study, 42 (93.3%) of people with intellectual disabilities 
and epilepsy had some investigations undertaken, with all 42 having had an electroencephalogram 
(EEG) (Matthews et al., 2008). Other investigation rates were low, particularly the use of neuro-
imaging, despite the recommendations of clinical guidelines that such investigations should be 




considered (Kerr et al., 2001).  Of 225 people with intellectual disabilities and epilepsy in an English 
city, 46.2% were reported to have had an EEG, and 41.3% a brain scan (Reuber et al., 2008).   Of 75 
in-patients in a treatment and continuing care service, 9% had no record of an EEG trace having been 
performed (Tiffin and Perini, 2001). In some cases this appeared to be due to the inability of the 
patient to cooperate with the investigation but previous EEG records may have been lost for those 
admitted from outside the region.  Only around 24% of patients with partial seizures received an 
MRI or CT scan, with failures due to poor cooperation being reported. 
 
Seizure diaries 
Medical intervention relies heavily on the accuracy of seizure frequency reporting (Clark et al., 
2001).  A small number of studies give information relating to seizure diaries.  Of people aged 40 or 
more with intellectual disability and epilepsy from Ireland, most respondents (83.1%) kept a record 
of their seizures, with those living in residential care (92.7%) more likely to have such a record than 
those living independently (43.5%) or in the community (77.8%) (McCarron et al., 2014).   A study in 
England of 20 people with intellectual disabilities who had died from SUDEP found seizure frequency 
documented in all case files except one, but sometimes only the approximate numbers of seizures 
(of all types) were documented, partly due to lack of access to the seizure diary during review    
(Kiani et al., 2014).  In an evaluation of an educational programme for people with mild intellectual 
disabilities and epilepsy, outcomes included increased understanding of the importance of seizure 
diaries, and increased knowledge regarding what, and when, to write in a seizure diary (Clark et al., 
2001).   
 
Medication adherence 
Non-adherence to AEDs in the general population has been associated with increased morbidity, 
SUDEP, increased health care costs, and increased number of emergency hospital visits, 
hospitalisations and injuries (cf. Hom et al., 2015).  In a US study, the non-adherence rate for AEDs 




was 6% for group homes, 20% for semi-independent settings, and 32% for family homes (Hom et al., 
2015).  The authors suggest that people with intellectual disabilities and their family members 
should be educated about the importance of medication adherence as they may not fully 
understand the consequences of non-adherence.   As noted in relation to an evaluation of an 
educational programme for people with mild intellectual disabilities, addressing lack of knowledge 
may help to ensure medication compliance (Clark et al., 2001).   
 
Management by proxy 
In relation to the pharmacological management of epilepsy for people with intellectual disabilities, it 
has been noted that they may be disadvantaged by a lack of self-advocacy (National Clinical 
Guideline Centre, 2012).  A small number of articles contain information relevant to the issue of 
management by proxy.  One study considered the role of parent-proxies in treatment decisions 
based on interviewing mothers of adults with intellectual disabilities and epilepsy (Redley et al., 
2013).  It is suggested that they were willing to live with what they considered to be an acceptable 
level of seizure activity and to reject possible changes in their son or daughter’s treatment.  Two 
questions are raised.  First, do mothers refuse suggested changes during consultations, and second 
do clinicians avoid going against their wishes?   In one survey, professionals commented on: high 
turnover of paid caregivers who accompanied patients to consultations; variation in accounts of 
individuals' seizures reported by different paid caregivers: an absence of accurate records; and the 
fact that some paid caregivers did not know the person they supported to the degree required in a 
consultation (Thompson et al., 2013).  Similarly, in an audit related to the setting up of a multi-
disciplinary specialist epilepsy clinic, it was noted that nonpaid carers gave a better account of the 
patient’s history, seizure descriptions and seizure frequency whilst in some cases paid carers were 
unfamiliar with the patient and their epilepsy (Whitten and Griffiths, 2007).  
Risk Assessment 




NICE guidelines state that people with intellectual disabilities should have a risk assessment 
including: bathing and showering; preparing food; using electrical equipment; managing prolonged 
or serial seizures; the impact of epilepsy in social settings; SUDEP; and the suitability of independent 
living, where the rights of the child, young person or adult are balanced with the role of the carer  
(National Institute for Health and Care Excellence, 2012).   
 
Little research regarding risk assessment was identified.  Following the setting up of a multi 
disciplinary specialist epilepsy clinic, all patients had risks discussed and 68% had risks identified, 
with appropriate referrals being made (Whitten and Griffiths, 2007).  
 
Two linked studies at a specialized epilepsy residential centre in the Netherlands examined decision-
making in relation to risk for people with intellectual disability and epilepsy (Vallenga et al., 2006, 
Vallenga et al., 2008).   Protective measures were often taken in situations of immediate threat, 
allowing no time to consider their negative effects, with consideration of these effects coming later 
(Vallenga et al., 2006).  Systematic recording and analysis of accidents was lacking.  The authors 
suggest that practice could be improved by a methodical approach to risk management, including 
observation and recording of specific individual risks, accidents and the circumstances in which they 
occur, including pre-existing protective measures.  In a subsequent study aiming to improve decision 
making regarding risk, assessment of client risk became more systematic and ‘steps to an individual 
framework for decision-making’ were developed as a tool for a systematic approach (Vallenga et al., 
2007).   
 
Managing prolonged or serial seizures (rescue medication) 
Rescue medication for managing prolonged or serial seizures can reduce the need for hospital 
admissions.  Clinical guidelines suggest that any individual with intellectual disabilities and epilepsy 
should have an assessment of the management of prolonged or cluster seizures and where rescue 




medication is prescribed a clear care plan should be completed (Kerr et al., 2001).  NICE guidelines 
recommend the administration of buccal midazolam as first-line treatment in children, young people 
and adults with prolonged or repeated seizures in the community, with administration of rectal 
diazepam if preferred or if buccal midazolam is not available (National Institute for Health and Care 
Excellence, 2012). Guidelines also state that buccal midazolam or rectal diazepam should only be 
prescribed for those who have had a previous episode of prolonged or serial convulsive seizures.   
A number of studies consider the issue of rescue medication.   In one English city, 15.6% of people 
with intellectual disabilities and epilepsy had to attend A&E at least once over the preceding year 
because seizures would not stop, and 5.3% attended more often (Reuber et al., 2008).    Of the 
27.6% of respondents who had a supply of rescue medication at home, only 42.6% had received 
training from a nurse or a doctor on how to give this medication. Only 40% of carers of people with 
intellectual disabilities and epilepsy who had been to A&E over the last year with a prolonged seizure 
had access to emergency medication.   
 
Two audits demonstrated increased recording regarding the use of rescue medication following the 
setting of standards (Whitten and Griffiths, 2007, Esan and Markar, 2010).  In the latter study, it was 
noted that some patients had no one to administer it or there were training issues with staff 
involved.     In relation to staff training, a survey of staffed homes in an English town in the non-
health sector (private, voluntary or local authority) found that of 11 homes with a client with 
epilepsy, less than half had staff trained to administer emergency AEDs (Deepak et al., 2012).    
Prescriptions written by the GP frequently did not include emergency AEDs.  It is noted that whilst 
the NHS trust has policy guidelines on training staff in emergency AED use, this did not seem to have 
been implemented at the community level.  
 




Buccal midazolam has been reported to be ‘vastly superior’ to rectal diazepam, being less likely to 
sedate patients, protecting their dignity, and being attributed with reducing the need to engage with 
emergency services (Thompson et al., 2013).  There was a general call for training in administration 
by family, paid caregivers, and GPs.   In a community population of people with intellectual 
disabilities and epilepsy, the use of buccal midazolam was much more prevalent that the use of 
rectal diazepam  (Mukhopadhyay et al., 2010).  Buccal midazolam was rated as better across a range 
of parameters: convenience of administration; invasiveness of procedure; gender issues; social 
acceptability; consent issues; and onset of action.   An Australian study on the use of intranasal 
midazolam found that it was effective at controlling seizures, with no instances of respiratory arrest, 
and only one report of apparent shallow breathing (Kyrkou et al., 2006).  However, the authors 
stress that adequate training is required in its use.   
 
One study evaluated individual epilepsy guidelines (IEG’s) which gave directions for administering 
emergency medication for people with intellectual disabilities and refractory epilepsy living in the 
community (Cole et al., 2009).  These were produced in response to concerns that in community 
settings many carers had difficulty recognising when rectal diazepam should be administered.  
Carers found the IEG’s easy to understand and were more informed about administering rectal 
diazepam as a result of the guidelines.  IEG’s could be viewed as a means of minimising patient/carer 
anxieties and stress during emergency events and reduce the need for hospital admissions with 
possible cost savings for the NHS.  Guidelines were also going to be developed for the use of buccal 
midazolam.   
 
Educating people with intellectual disabilities about their epilepsy 
People with intellectual disabilities and epilepsy may benefit from education regarding the 
management of their condition.  There has been little research on this issue.  A Scottish study has 
evaluated a video assisted educational package ‘Epilepsy and You’ for people with mild intellectual 




disabilities and epilepsy (Clark et al., 2001).  Epilepsy and You’ involved participants participating in 
three, weekly sessions each lasting one hour.  Participants increased greatly in their knowledge 
about what an EEG is and the importance of seizure diaries, with increased knowledge about what, 
and when, to write in a seizure diary.   The authors suggest that addressing lack of knowledge may 
help in relation to ensuring medication compliance and prevent the generation of false and 
distressing beliefs regarding epilepsy.   Two other articles concerning educating people with 
intellectual disabilities and epilepsy, which did not meet the inclusion criteria for the review, are 
discussed in the discussion section (Codling, 2010, Durand et al., 2014). 
 
Evaluations of initiatives in service provision 
 
In an English county, an intellectual disabilities psychiatric service was established after a five year 
period without one (Beber et al., 1999).  At baseline, most received GP care only for their epilepsy.  
Intellectual disabilities psychiatric care was found to be associated with reductions in seizure 
frequency, drug side-effects and polypharmacy. Those receiving intellectual disabilities psychiatric 
care were more likely to have: type of seizure determined; medical reviews; appropriate blood test 
monitoring; active interventions to improve seizure control; and to have unnecessary drugs 
withdrawn.  Some of those not under intellectual disabilities psychiatric care tended just to receive 
repeat prescriptions for their epilepsy. 
 
In one area of England, an audit of adherence to standards based on NICE guidelines was conducted 
in a specialist epilepsy clinic for people with intellectual disabilities (Esan and Markar, 2010).  At 
initial audit, 11 of 21 standards were met and the following recommendations were made: all 
patient records kept in one file; user friendly leaflet developed giving information on medication 
changes, care plan, contacts with clinic and next appointment date; NICE information booklet given 
to patients and carers after appointments; checklist developed detailing main areas that needed 




improvement to serve as reminder to psychiatrist at clinic; standardised risk assessment form 
developed to complete and share with carers or other agencies; leaflet on SUDEP developed.  The 
subsequent audit found an improvement in meeting standards which was of benefit to both service 
users and clinicians.   
In another area of England NICE guidelines were implemented through the introduction of a 
specialist multi-disciplinary epilepsy clinic (Whitten and Griffiths, 2007). There were improvements 
to seizure assessments, matching of medication to seizure type, patient care and epilepsy 
management.  All patients prescribed three or more AEDs received a medication reduction plan and 
all patients received an individualised risk assessment.   In Wales, audit was used to look at the 
impact of standard setting in a clinic for people with intellectual disabilities and epilepsy (Chubb et 
al., 1995).  There was improvement in several areas of out-patient management but the recording of 
side effects and comments on quality of life were poor both before and after audit.   
 
A study in Belgium  looked at the introduction of a decision tree, for non-medically trained staff in 
two establishments for adults with intellectual disabilities, which treats seizures as medical 
emergencies (Peeters, 2000).  Treatment of seizures as medical emergencies reduced frequency, 
duration, and severity (in comparison with results from a retrospective review). No patient was 
hospitalized.  The authors note that use of the decision tree could also be taught to caregivers and 
parents. 
An early study in the United States looked at outcomes for 15 people with severe to profound 
intellectual disabilities and complex epilepsy who were moved from an institution to specially built 
community based group homes despite the expression of concerns that the needs of this medically 
fragile group could not be met in the community (Litzinger et al., 1993).  It was found that 
simplification of anticonvulsants, early intervention for seizures, and improved staff education 
resulted in fewer seizures, decreases in emergency room visits for status seizures and drug-related 




side effects, and increased levels of functioning as measured by activities of daily living. The success 
of the community placement was attributed by authors to the availability and proper usage of the 
new generation of AEDs. 
A study in an area of England piloted three care pathways (Ahmad et al., 2007), of which one was for 
epilepsy (cf. Ahmad et al., 2002).    The percentage attained for training offered to clients and carers, 
and results sent to the GP, increased after the introduction of the epilepsy care pathway.     
Prescribing Practices 
Polypharmacy was common reflecting difficult to treat epilepsy in this population.  Of 183 people 
with intellectual disabilities and epilepsy in one geographic area of England, 36% were being treated 
with two AEDs and 23% were prescribed three or more AEDs (Ring et al., 2009).  In Wales, of 57 
participants 40% were prescribed two AEDs, 9% three AEDs and 4% four AEDs (Matthews et al., 
2008).  It was noted that whilst polypharmacy was common, this and dosage were related to higher 
seizure frequency, which may reflect an appropriate response to the morbidity. One study suggests 
that some people may benefit from a reduction in the number of AEDs prescribed.  In an audit of 
AED use in adult in-patients with intellectual disabilities in a treatment and continuing care service, 
13 (17%) were identified as potentially benefiting from a reduction in the number of AEDs they were 
prescribed (Tiffin and Perini, 2001).  
 
In an early study of people with intellectual disabilities who were receiving AEDs in one English 
county, no difference in polypharmacy was found between those in NHS and community facilities, 
but there was an association between polypharmacy and the degree of involvement of specialist 
intellectual disability services (Branford and Collacott, 1994).  There were differences in the choice of 
AEDs with those outside the NHS more likely to receive phenytoin, phenobarbitone & primidone 
which have been shown to have particularly poor effects on cognitive performance.  A follow-up 




study found continued reduction of the prescribing of phenobarbitone and increased prescribing of 
sodium valproate and carbamazepine (Branford et al., 1998). 
 
A theoretical concern is that patients with intellectual disabilities might not be offered treatment 
with newer AEDs as often as other patients, potentially due to a lack of advocacy in favour of using 
newer AEDs by patients with intellectual disabilities or their caregivers (Fridhandler et al., 2012).  A 
recent Canadian study looked at AED prescribing practices for patients with and without intellectual 
disabilities in a tertiary epilepsy center (Fridhandler et al., 2012).  There was no evidence for a 
discrepancy in access to new AEDs in patients with intellectual disabilities. Similarly, the authors of 
one study suggest that over the years the pharmacological management of epilepsy in people with 
intellectual disabilities has been modified according to emerging changes in clinical practice 
recommendations (Ring et al., 2009).  However, a survey in an English city found that only one in 10 
patients under primary care review was taking one of the ‘‘newer’’ AEDs (Reuber et al., 2008).  
Finally, in an Irish study, a number of people who reported a history of seizure activity were not 
taking medication despite experiencing seizures, with this group tending to be those with mild or 
moderate intellectual disabilities who lived in the community or independently (McCarron et al., 
2014).   
 
Views of families, carers or professionals regarding services 
A qualitative study explored the views of carers and professionals from the UK and Ireland into the 
management of people with intellectual disabilities and epilepsy (Thompson et al., 2013).  In relation 
to ‘medical care and services’, some respondents argued that the medical profession had lower 
expectations of whether seizure freedom was possible for this population.  Respondents, largely 
family members, commented on the ‘trade-off’ between the goal of achieving seizure control on the 
one hand and the impact of side effects from medication on the other hand. Some family members 
reported their distress at the price paid in side effects in order to gain seizure control.  




A small number of professionals stated that caregivers should be better informed about the ‘blind 
target’ to eliminate seizures given the negative impact treatment may have on the individual’s 
overall quality of life. 
 
A US study identified sources of stress for parents of children with both epilepsy and intellectual 
disability (Buelow et al., 2006).  Most seemed fairly happy with their children’s healthcare providers, 
but did discuss concerns about medications and a lack of information regarding their child’s illness.  
Whilst some complained about medications and side effects, they did not have suggestions as to 
actions healthcare providers could take regarding seizure treatment. 
 
In an audit on communication between GPs and psychiatrists following an initial outpatient 
assessment of patients with intellectual disabilities, 30 GPs responded to a survey and one of the 
comments made on how to improve the service was that psychiatrists should take over the 
management of epilepsy (Markar and Mahadeshwar, 1998).   
 
An international online survey obtained responses regarding service delivery for people with 
intellectual disability and epilepsy  from professionals and carers, mainly from the UK (Kerr et al., 
2014).  There were calls for: greater resources including multidisciplinary team approaches; 
specialist nursing; provision of local services; consistency in quality of service provision; and greater 
recognition of family. There were concerns regarding lack of expertise in primary care; brief and 




Despite the broad inclusion criteria which allowed for the identification of research on disparate 
topics within the broad area of service responses to epilepsy in people with intellectual disabilities, 




no RCTs or studies employing similarly robust designs were identified.   The articles identified 
consisted mainly of small scale surveys, audits, and qualitative studies.  Nonetheless, the findings of 
this review elucidate key issues emerging from research in this area. 
 
Descriptions of current service provision suggest that access to specialists is inconsistent, with 
geographical distribution of expertise being termed a ‘postcode lottery’ within the UK (Thompson et 
al., 2013).  In addition, a report based on a survey in England found that  49% (40/79) of acute and 
foundation trusts did not offer patients access to intellectual disability epilepsy specialist nurses 
(Epilepsy Action, 2013).   A report based on a survey undertaken under the auspices for the 
Intellectual Disability Task Force of the International League against Epilepsy (ILAE) and the 
International Bureau for Epilepsy (IBE) found that an overarching theme across many responses was 
an endorsement for specialist care, ranging from epilepsy nurse specialists through to 
multidisciplinary teams (Kerr et al., 2013).   
 
Despite calls for specialist care, there was very little evidence in relation to the relative efficacy of 
different models of service provision although there was some indication that service settings and 
service provision may make a difference to outcomes for people with intellectual disabilities and 
epilepsy.  Further evidence is crucially needed in this area.  In this respect, there is an ongoing 
cluster randomised controlled trial which is aiming to establish whether nurses with expertise in 
epilepsy and intellectual disabilities can improve clinical and quality of life outcomes in the 
management of epilepsy in adults with intellectual disabilities compared to treatment as usual (Ring 
et al., 2014).   
  
In some areas, the lack of research is surprising.  There is very little research regarding the use of 
epilepsy care plans, seizure diaries, or risk assessments.  There is some research with regards to 
managing prolonged or serial seizures which generally supports the usefulness of rescue medication 




(in particular buccal midazolam).  However, one issue was the lack of suitably trained staff or carers 
to administer such medications (Deepak et al., 2012, Esan and Markar, 2010).  Only one evaluation 
on the impact of a care pathway for people with intellectual disabilities and epilepsy was identified 
(Ahmad et al 2007), although a care pathway has also been developed in an English county (Kiani et 
al 2014).    
 
One evaluation of an educational package for people with mild intellectual disabilities and epilepsy 
met the inclusion criteria (Clark et al., 2001).  However, it is evident that other educational 
programmes have been developed, but research evaluating their use is currently limited.   For 
example, an English version of a German multi-media programme (PEPE: a psycho-educative 
programme about epilepsy for people with intellectual disabilities) designed to give people with 
intellectual disabilities and epilepsy information and support has been developed in association with 
the National Society for Epilepsy (Kushinga, 2007).  However, there have been relatively few 
initiatives that attempt to measure the effectiveness of this resource (Codling, 2010).  One study 
(which has not been included in the main review as peer review status was not determined), which 
used the PEPE programme alongside other methods such as group discussions and role-play, found 
that the groups had an impact on the ability of people with intellectual disabilities to manage their 
epilepsy, including an increased awareness amongst people with intellectual disabilities about risk 
(Codling, 2010).  Group sessions highlighted anxiety caused by interpretation of information given by 
health staff.   For instance one member was informed that people can die from epilepsy and so they 
became frightened to go to sleep, leading to increased seizures.   One feasibility study was identified 
which is being used to inform the design and methodology of a study to determine the impact of an 
intervention  to improve the management of epilepsy in people with intellectual disabilities based 
on a ‘Books Beyond Words’ booklet that uses images to help people with intellectual disabilities 
manage their epilepsy (Durand et al., 2014).  Finally, evaluations of training initiatives for staff have 
not been identified although such initiatives exist (Sterrick and Foley, 1999, Pointu and Cole, 2005).    





In addition, a number of relevant measures have been developed, but there is little research 
evaluating their use.  For example, the epilepsy risk awareness checklist (ERAC) provides a measure 
of risk, and initial research suggests that it is a useful tool in the care of people with intellectual 
disability and epilepsy (Cole et al., 2010).  The Epilepsy and Learning Disabilities Quality of Life scale 
(ELDQOL) has been reported to be a promising instrument for assessing quality of life in children or 
young adults with epilepsy and intellectual disabilities (Buck et al., 2007).  The Glasgow Epilepsy 
Outcome Scale (GEOS; GEOS-35 and GEOS-90 versions) has been developed to measure concerns of 
family carers, staff carers and clinicians for people with intellectual disabilities and epilepsy (Espie et 
al., 2003, Espie et al., 2001).  A client version of the GEOS (GEOS-C) has also been developed for use 
with people with mild to moderate intellectual disabilities to complement existing GEOS measures 
(Watkins et al., 2006).  Development of the GEOS-C revealed some qualitatively different concerns to 
those of family carers, staff carers and clinicians, such as wetting self during seizure, feeling 
embarrassed if having a fit when out, and people calling me names when I have a fit.   The existing 
scales may have useful applications in both research and practice.    
 
Further research is also being carried out on the identification of situations associated with 
increased or decreased seizure likelihood in people with intellectual disabilities due to the potential 
for informing nonpharmacological approaches to seizure management that may provide a useful 
adjunct to AED treatment (Illingworth et al., 2014). 
 
Limitations 
There are a number of limitations to this review.  A main weakness is the potential loss of 
information from two main sources due to the focus on studies relating to the general population of 
people with intellectual disabilities.  Firstly, the review has not considered how studies regarding 
services approaches to epilepsy in general may be applicable to people with intellectual disabilities, 




and indeed some of these studies may include information relating to intellectual disabilities.  
Secondly, the review does not consider research relating to specific syndromes associated with 
intellectual disabilities such a Lennox Gastaut or Dravet syndrome.  These sources of information 
remain to be reviewed.  In addition, whilst studies were identified from a range of countries, the 
review is restricted to English language publications.  No information was identified regarding 
services responses to people with intellectual disabilities and epilepsy in low and middle income 
(LAMI) countries.  Indeed, the majority of studies were conducted in the UK.  Further, whilst no 
publications prior to 1990 were included, descriptions of service provision or initiatives from older 
articles based on historically prevalent models of service provision may not be as relevant as more 
current studies.  Finally, all data was extracted by one reviewer and extraction of data by two 
reviewers independently would have reduced the possibility of errors.   
 
Conclusion 
Research into service responses to epilepsy in people with intellectual disabilities is at an embryonic 
stage.  Whilst initiatives to improve service responses to people with intellectual disabilities and 
epilepsy exist, evaluations of such initiatives are lacking.  Further research is needed to substantiate 
some of the findings reported here and the results of ongoing research will be a welcome addition to 
the evidence base.  It is important that services are equipped with the information and skills needed 
to manage epilepsy in this population.  A recent report provides information on reasonable 
adjustments that can be made to improve epilepsy care for people with intellectual disabilities 
(Marriott et al., 2014)   The ideas, information and examples of good practice in relation to 
reasonable adjustments provided within this report should help services improve provision for this 
highly prevalent condition and potentially reduce the excess deaths associated with epilepsy in 
people with intellectual disabilities.   
 
 




Appendix One: Electronic Search Strategy 
CINAHL (searched 20.1.15) 
Limits: English, Human, Peer reviewed, published  from 1990. 
Results 176 
(TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or disab* or 
deficien* or handicap*) ) OR TI ( intellectual* N1 (disab* or impair* or handicap*) ) OR TI 
development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI "Down* syndrome" OR 
(MH "Developmental Disabilities") OR (MH "Intellectual Disability+") OR  (MH "mentally disabled 
persons")) OR  (AB ( learning N1 (disab* or difficult* or handicap*) ) OR AB ( mental* N1 (retard* or 
disab* or deficien* or handicap*) ) OR AB ( intellectual* N1 (disab* or impair* or handicap*) ) OR AB 




(MH "Epilepsy+/CO/DI/DH/ED/NU/PC/PR/PF/RH/RF/TH") OR ( TI epilep* OR TI seizure* OR AB 




AB training OR AB ( care n1 (plan* or manag* or pathway) ) OR AB ( risk n1 (manag* or assess*) ) OR 
AB ( medic* n1 (emergency or rescue) ) OR AB ( diar* n1 (seizure or epilep*) ) OR AB ( medic* n1 
(compliance or adherence) ) OR AB guidelines OR AB ( review n1 (epilep* or annual) ) OR AB ( 
manag* n1 (seizure or epilep*) )  OR  TI training OR TI ( care n1 (plan* or manag* or pathway) ) OR TI 
( risk n1 (manag* or assess*) ) OR TI ( medic* n1 (emergency or rescue) ) OR TI ( diar* n1 (seizure or 
epilep*) ) OR TI ( medic* n1 (compliance or adherence) ) OR TI guidelines OR TI ( review n1 (epilep* 




or annual) ) OR TI ( manag* n1 (seizure or epilep*) )  OR (MH "Health Services Administration+")  OR 
(MH "Health Services+")  
  
Medline (searched 20.1.15) 
Limits: English, Human, published from 1990. 
Results 1164 
As Cinahl (above) with amended subheadings as follows:   
(MH "Epilepsy+/CO/DI/DH/NU/PC/PX/RH/TH") 
 
PsycINFO (searched 21.1.15) 
Limits: peer reviewed, human, English language, published from 1990, exclude dissertations. 
Results 184 
 
( (((((DE "Social Services" OR DE "Community Services" OR DE "Outreach Programs" OR DE 
"Protective Services")) OR (DE "Health Care Services" OR DE "Continuum of Care" OR DE "Long Term 
Care" OR DE "Mental Health Services" OR DE "Primary Health Care")) OR (DE "Health Care 
Administration" OR DE "Hospital Administration")) OR (DE "Caregivers")) OR (DE "Managed Care" OR 
DE "Health Maintenance Organizations" OR DE "Mental Health Programs" OR DE 
"Deinstitutionalization" OR DE "Home Visiting Programs" OR DE "Quality of Care" OR DE "Quality of 
Services" OR DE "Quality of Care") ) OR ( AB training OR AB ( care n1 (plan* or manag* or pathway) ) 
OR AB ( risk n1 (manag* or assess*) ) OR AB ( medic* n1 (emergency or rescue) ) OR AB ( diar* n1 
(seizure or epilep*) ) OR AB ( medic* n1 (compliance or adherence) ) OR AB guidelines OR AB ( 
review n1 (epilep* or annual) ) OR AB ( manag* n1 (seizure or epilep*) ) OR TI training OR TI ( care n1 
(plan* or manag* or pathway) ) OR TI ( risk n1 (manag* or assess*) ) OR TI ( medic* n1 (emergency 
or rescue) ) OR TI ( diar* n1 (seizure or epilep*) ) OR TI ( medic* n1 (compliance or adherence) ) OR 
TI guidelines OR TI ( review n1 (epilep* or annual) ) OR TI ( manag* n1 (seizure or epilep*) ) 





DE "Intellectual Development Disorder" OR DE "mental retardation" OR DE "developmental 
disabilities" OR (TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or 
disab* or deficien* or handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or 
handicap*) ) OR TI development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI 
"Down* syndrome") OR AB ( mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) 
OR AB ( intellectual* N1 (disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB ( 
multipl* N1 (handicap* or disab*) ) OR AB "Down* syndrome" 
AND 
DE "Epilepsy" OR DE "Epileptic Seizures" OR (DE "Seizures" OR DE "Audiogenic Seizures" OR DE 
"Epileptic Seizures" OR DE "Grand Mal Seizures" OR DE "Petit Mal Seizures" OR DE "Status 
Epilepticus") OR ( TI epilep* OR TI seizure* OR AB epilep* OR AB seizure*)  
 
Web of Science (searched 21.1.15) 
Limits: English language; published from 1990; articles. 
Results 337.   
 
learning NEAR/1 (disab* or difficult* or handicap*) OR mental* NEAR/1 (retard* or disab* or 
deficien* or handicap*) OR intellectual* NEAR/1 (disab* or impair* or handicap*)  OR development* 
NEAR/1 disab* OR multipl* NEAR/1 (handicap* or disab*) OR "Down* syndrome"  
(In TOPIC which includes title, abstract, keywords) 
AND 
Epilep* or seizure* 
AND 
training  OR  care NEAR/1 (plan* or manag* or pathway)  OR  risk NEAR/1 (manag* or assess*)  OR 
medic* NEAR/1 (emergency or rescue)  OR diar* NEAR/1 (seizure or epilep*)  OR medic* NEAR/1 




(compliance or adherence) OR guidelines OR review NEAR/1 (epilep* or annual)  OR manag* NEAR/1 
(seizure or epilep*)  OR service* 
Clinical Trials Registers (searched 28.9.15) 
ClinicalTrials.gov (U.S. National Institutes of Health):  Intellectual and epilepsy (15 results, 0 
selected); “Mental retardation” and epilepsy (5 results, 0 selected)  
Cochrane Central Register of Controlled Trials (CENTRAL): Intellectual and epilepsy (56 results, 0 
selected);  “Mental retardation” and epilepsy (26 results, 0 selected) 
ISRCTN registry (http://www.controlled-trials.com/):  Intellectual (text) and epilepsy (condition) (2 
results, both selected, both ongoing trials); Mental retardation (text) and epilepsy (condition) (5 
results, 0 selected) 
UK Clinical Trials Gateway: Intellectual and epilepsy (11 results, 2 selected, both already identified in 
ISRCTN search); Mental retardation and epilepsy (15 results, 0 selected) 
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Table One: Summary of studies regarding service responses to people with intellectual disabilities & epilepsy1 
Author Country Focus Design Sample source Sample Size Sample features Outcome 
measures 
Results 
Ahmad et al 
2007 
England Impact evaluation 
of epilepsy care 
pathway initiative 
for people with 
intellectual 
disabilities 
Auditor assessed pilot site 
service on parameters 
prior to & 3 months after 
introduction of care 
pathways (3 pathways in 
initiative, 1 of which 
epilepsy) 
6 pilot sites in West 
Midlands 




models of service 





to clients & 
carers, & 
results sent to 
the general 
physician pre- 
& post epilepsy 
care pathway 
% pre-/post approximated from bar chart: client training 16% v 35%; carer 
training 50% v 88%; results to GP 16% v 54% 
Baribeault 
1996 
US Clinical advocacy Descriptive information 
based on practice 
Adults living in residential 
group homes with 
epilepsy for whom the 




21 Adults with 
intellectual 
disabilities & 




AED use After the clinical advocate collaborated with the prescribing neurologist to 
complete a review of seizure history & AED use, 12 (58%) had AEDs 
reduced or eliminated.  The 21 participants saw neurologists scattered 
throughout the community from group practice to teaching hospitals.  The 
author suggests that many neurologists in the community may tend towards 
a 'status quo' or maintenance type of prescribing so if no worse & no AED 
effects, AEDs remain unchanged.  A clinically skilled advocate participating 
in the consultation led to more precise objectives being formulated. 
Beber et al 
1999 









between baseline & 
outcome measurements 
for those who did (for min 
1 year, max 2 years), 
compared to those who 
did not receive psychiatric 
care  
Those living in NHS 
accommodation or 
referred to the learning 
disabilities psychiatric 
service; or using NHS 
respite care & not 
accessing learning 
disabilities psychiatric 









17-66 years, 37 
men & 31 











Learning disabilities psychiatric care was found to effect reduced seizure 
frequency, with a reduced frequency of drug side-effects & reduced 
frequency of polypharmacy. The type of the person's seizures was more 
likely to be determined, medical reviews & appropriate blood test monitoring 
conducted & active interventions made to improve seizure control & to 
withdraw unnecessary drugs, if the person was receiving learning disabilities 
psychiatric care. Almost all of these results were highly statistically 
significant. 
Beran et al 
1992 
Australia Knowledge & 
attitudes of 
nurses working 




Postal survey Random sample of 100 
institutionally based 
nurses out of 385 
employed by a regional 
developmental disability 
service.   




between 35 & 45 
(30 nurses).  





seizure type to 
unambiguous 
descriptions of 
a variety of 
seizures  
75% unable to correctly diagnose a complex partial seizure.  > 60% confused 
terms such as absences, atonic seizures & myoclonic seizures.  None 
correctly identified a pseudoseizure.  They had no problem diagnosing a 
generalized tonic clonic seizure or status epilepticus.  In open ended 
comments, the most frequent response was an identified need for in-service 
lectures to include discussion of AEDs, clarification of terminology, 
discussion of aetiology & management of epilepsy & the issuing of frequent 
information updates.  They also wanted greater input to teach them what 
they should observe during seizures.   
                                                          
1
 Terms for intellectual disabilities are given as used in the studies e.g. ‘learning disabilities’ is often used in the UK 









England AED prescribing 
practices 
Cross-sectional survey 
based on NHS facility 
records or day centres, 
homes, hostels & 
interviewing carers.  
Comparison of NHS & 
community facilities  
Leicestershire Learning 
Disability Register (LIDR) 
381 Adults with 
seizure disorder 








240 (63.0%) on monotherapy, 125 (32.8%) on two AEDs & 16 (4.2%) on 3 
AEDs. The most frequently used were carbamazepine (80.1% of NHS, 
54.8% of community, chi square 27.06, p < .001) & sodium valproate (31.6% 
NHS, 29.5% community, ns).  Phenytoin (5.3% NHS, 21.4% community, chi 
square 20.15, p < .001),  phenobarbitone (11.1% NHS, 23.3% community, 
chi square 9.58, p < .001),  & primidone (which is metabolized to 
phenobarbitone) (0.0% NHS, 5.7% community, chi square 10.11, p < .001) 
were used significantly more frequently by those living in non-NHS settings.   
The specialist learning disability service was directly involved with the 
supervision of seizure control for all in NHS facilities & 49% in community 
facilities, with a lesser degree of involvement for a further 22%.  There was 
no involvement for less than 30% of those in the community.   Degree of 
specialist service involvement was associated with reduced polypharmacy 
(chi square 9.69, p <.05).  There was an association between increased age 
& the prescribing of phenytoin & phenobarbitone with the association being 
similar for both NHS & community facilities. 
Branford et 
al 1998 
England AED prescribing 
practices 
Survey, questionnaire 
completion by key carers, 
comparison to findings of 
previous study involving 
same participants who 
were initially living in 
institutional settings 
Leicestershire Learning 
Disability Register (LIDR) 
138 80 (58%) male & 
58 (42%) female. 
Mean age 47 
years (SD 12.59) 
& 63% profound 
learning 
disabilities. 74 
(54%) in NHS 
accommodation, 
64 (46%) in 
community 




& drugs used 
A greater proportion had active epilepsy in 1997 (71%) than in 1985 (58%). 
The deterioration in seizure control occurred despite an increase in 
polypharmacy, the introduction of new AEDs & in some cases increases in 
dosage.   There was continued reduction of the prescribing of 
phenobarbitone & increased prescribing of sodium valproate & 
carbamazepine. This change would be in line with the aims of the original 
review programme & constitutes good medical practice. 
Buelow et al 
2006 
US Sources of 
parental stress 





Semi-structured face to 
face interviews & 
qualitative analysis 
Pediatric neurology & 
epilepsy clinics, a 
pediatric neurologist in 
private practice, & school 
nurses 
20 18 mothers, 1 
father, 1 dyad.  
Children age 9-
19 (mean 12.2, 







Five categories of sources of stress were identified, one of which was 
communication with healthcare providers.  There were concerns about 
medications & a lack of information regarding their child’s illness.  Several 
had experienced problems obtaining a diagnosis.  Some felt doctors ignored 
what they felt to be significant side effects of medication.  Parents commonly 
expressed the need for more information about their child’s condition in 
relation to future course, situations about which they should be concerned, & 
a need for information on medications particularly side effects.  













Survey of symposium 
attendees 
254 attendees at 
symposium on Lennox 
Gastaut syndrome & 






91.7% from US 
% responses to 
survey items 
Factors that make it challenging to transition a patient with epilepsy & 
intellectual disability to adult care:  attachment of the family & patient to the 
respondent (62%); concern that an adult neurologist will take less time with 
the patient & his/her family than the respondent has in the past (42%); 
respondent’s attachment to the patient/family (41%), lack of adult neurologist 
willing to care for adults with epilepsy & intellectual disability (35%); concern 
that an adult neurologist would not be familiar with the patient’s neurologic or 
medical condition (33%); other (18%); & too much time needed to coordinate 
care & complete the transition (17%).  For ‘other’ the most common specified 
response was ‘‘financial/insurance issues’’ (e.g., with neurologists not 
wanting to take Medicaid patients). 
Chubb et al 
1995 
Wales Audit of out-
patient care 
Classical audit cycle: 
recognition of areas of 
concern, setting of 
standards, measuring of a 
baseline, & evaluation of 
effect of standard setting 
on this baseline 
Patients attending 
Developmental Epilepsy 
Clinic (established in 
1991) run by the learning 
disability services at the 
University Hospital of 
Wales, Cardiff.    
24 Mean age 31.5 
years (range 6-
66), 58% females 
% of times 
standard 
reached  
Significant improvements were seen in recording of monthly seizure rate by 
seizure type; legibility of signature; regular letter to GP; writing seizure 
frequency in letter to GP.   Some standards showed no significant 
improvement because the pre-audit standard was high. Others, in particular 
the recording of side effects (22.3% before, 33.3% after) & comments on 
quality of life (52.8% before, 58.3% after) were poor both before & after audit.  
Clark et al 
2001 








Deferred entry to 
treatment design: 8 in 
treatment group & 10 in 
deferred treatment group 
Adult training centres (n 
=2), a residential village 
for adults with a learning 
disability (n =3), a 
residential hostel for 
adults with a learning 
disability & epilepsy (n =8) 
& an adult training centre 
for individuals with a 
learning disability & 
epilepsy (n =5). 
18 Mild intellectual 
disabilities.  One 
or more seizures 




communication.   
Before/after 
scores on 






Knowledge increased on the majority of items on the checklist. Subjects 
increased greatly in their knowledge about what an EEG is & about the 
importance of seizure diaries; both issues fundamental to the management 
of epilepsy.   Subjects also demonstrated increases in their knowledge about 
what, & when, to write in a seizure diary & demonstrated increased 
understanding of why seizures happen.  There was no increase in 
knowledge for the deferred treatment group.    All subjects completed the 
Evaluation Questionnaire & stated that they enjoyed ‘Epilepsy & You’.  
Increased knowledge was maintained at 4 week follow-up.    
Cole et al 
2009 










Service evaluation of 
IEGs through a postal 
survey of carers 
Carers (support 
workers/family carers) of 
44 people who had 
received an IEG from 












% responses to 
survey items 
34 (80%) of the carers utilised the IEGs every time an individual had an 
epileptic seizure.  39 (93%) carers found the IEGs easy to understand & 37 
(88%) carers were more informed about carrying out the procedure of 
administering rectal diazepam as a result of IEGs.  40 (95%) carers were 
certain when to administer rectal diazepam & 36 (86%) claimed that the IEGs 
made it easier for clarification.  Only 23 individuals were prescribed oral 
clobazam medication, alongside the prescription of rectal diazepam. The 
responses indicated that 20 (93%) carers were certain when to administer 
oral clobazam. Only 3 (7%) of the responses indicated they were uncertain. 
37 (88%) carers agreed that they had become familiar with their clients 
epilepsy due to the IEGs.  




Author Country Focus Design Sample source Sample Size Sample features Outcome 
measures 
Results 
Deepak et al 
2012 
England Care home staff 





completed with care home 
managers  
Staffed homes in High 
Wycombe in the non-
health sector (private, 
voluntary or local 
authority) 
21 care homes 
(of total 22) 
Care home 
managers in 21 
non-health sector 
care homes 
% responses to 
survey items 
11 of 21 care homes had a client with epilepsy.  5 of these 11 (45%) had 
staff trained to administer emergency AEDs.  Hence, 55% of the 11 care 
homes with a client with epilepsy did not have staff trained in emergency 
AED administration.   Of the 10 care homes with no clients with epilepsy, 
none had staff trained to administer AEDs but 7 had arrangements for in 
house training if a client with epilepsy were placed there.  One home had a 
policy of only accepting clients with well controlled epilepsy.  Others reasons 
for non-training included non-awareness of need for training, & not having 
patients with prescribed emergency AEDs. 
Esan et al 
2010 
England Audit on 
adherence to 
NICE 2004 
guidelines in a 
specialist 






& audit repeated 2007.  
Based on review of letters 
to GPs not handwritten 
notes 
Multidisciplinary epilepsy 
clinic for people with 
learning disabiliites 
running > 10 years.  Held 
at outpatient dept of 
general hospital.   
All 45 regular  
patients  
All regular 









At initial audit, 11 of 21 standards were met.  At re-audit, some improvement 
in assessment of AED effrectiveness, AED tolerability, requesting EEG, 
CT/MRI, measuring of serum calcium & vitamin D levels, tests of bone 
metabolism, providing written & visual information about epilepsy, discussing 
quality of life, safety issues, provision of diazepam protocol, & provision of 
information about SUDEP.  The specialist epilepsy service showed 
improvement in meeting standards & this was of benefit to both service users 
& clinicians.   With regards to rectal diazepam, some patients had no one to 
administer it or there were training issues with staff involved.   
Fridhandler 
et al 2012 
Canada AED prescribing 
practices 
Retrospective review of 
physician notes, letters, & 
pharmacy reports.  
Comparison of those with 
& without intellectual 
disabilities  
Patients seen between 
2009 & 2011 at Epilepsy 
Clinic at the Toronto 
Western Hospital 








age 33.1 (SD 
1.92), 44% male, 
84% drug 
resistant (ILAE 
criteria).  Control 
group mean age 
45.4 (SD 2.05), 
34% male, 74% 
drug resistant.   
AED receipt 
(current & past) 
Those with intellectual disabilities currently & historically prescribed a greater 
total number of AEDs (currently 2.7 v 1.8).  More were taking at least one old 
AED (72% v 58%) but there was no difference in the number historically 
prescribed an old AED (76% v 88%).  There was no difference in the number 
currently (70% v 64%) or previously (66% v 60%) taking a new AED.   More 
of those with intellectual disabilities were currently (54% v 24%) & previously 
(58% v 28%) prescribed a benzodiazepine.  No evidence for a discrepancy in 
access to new AEDs in patients with intellectual disabilities.    
Frost et al 
2003 
England Implementation 




750 randomly selected 
health professionals: 
specialist epilepsy nurses 
(200), adult consultants 















% responses to 
survey items 
Most questions relate to epilepsy care generally.  A dedicated clinic for 
people with learning difficulties was noted to have been implemented by  
31.6% of 215 who answered the question, not implemented by 62.8% & 
attempted by 5.6% 




Author Country Focus Design Sample source Sample Size Sample features Outcome 
measures 
Results 
Hom et al 
2015 
US Adherence to 
AEDs & living 
situation 
Retrospective analysis of 
a closed Medicaid 
pharmacy billing system 
over a 30 month period 
(2000 to 2002).   
Client data of regional 
centre coordinating 
services for people with 
intellectual disabilities 
(linked by social security 
number to billing system). 
All included had filled 
prescriptions for AEDs 
spanning at least 6 
months.  











Most adults lived 
in group homes 
(74.3%), most 







of days each 
participant was 
in possession 
of an AED), & 
defined non-
adherence as 




of an AED.  
The non-adherence rate for AEDs was 5.96% for group homes, 20.00% for 
semi-independent settings, & 31.72% for family homes.  Controlling for age & 
gender using logistic regression, participants living in semi-independent 
settings had a  4.14-fold increase in the odds of prescription non-adherence 
(95% CI: 1.93, 8.84; P < 0.001), & participants living in family homes had a 
6.05-fold increase in the odds of prescription non-adherence compared with 
those living in group homes (95% CI: 3.54, 10.36; P < 0.001).     











International online survey 
of professionals, paid 




including national epilepsy 
associations, support 
groups, & professional 
networks, located in 7 
countries promoted the 
survey either via their 
website &/or by 
distributing documentation 
to their members 









Within the area of service delivery, the key themes identified from responses 
were:  calls for greater resources including multidisciplinary team 
approaches; specialist nursing; provision of local services; consistency in 
quality of service provision; & greater recognition of family. Concerns 
regarding lack of expertise in primary care; brief & ineffective consultations. 
Calls for greater use of epilepsy nurse specialists in training. 
Kiani et al 
2014 
England SUDEP Retrospective study of 
adults who died from 
SUDEP between 1993 & 
2010 
Leicestershire Learning 
Disability Register (LIDR) 






Adults on LIDR 
who died from 
definite or 
probable SUDEP 





13 (65%) had an Epilepsy Care plan & similar number had a 
prescription/written protocol for the use of a rescue medication.  No recorded 
evidence found of SUDEP being discussed with patients or their 
families/carers.   Although seizure frequency was documented in all case 
files except one, this was not reported in detail; sometimes only the 
approximate numbers of seizures (of all types) were documented, partly 
owing to lack of access to the seizure diary during the review.  Generally 
record keeping following the adult’s death was poor. Only 5 medical case 
files (25%) recorded the news of the patient’s death & any communication 
between the clinical team & family after the death of the patient including 
discussion on referral for bereavement counselling.  




Author Country Focus Design Sample source Sample Size Sample features Outcome 
measures 
Results 
Kyrkou et al 
2006 
Australia Community use 
of intranasal 
midazolam (INM) 
Survey of parents, carers 
& education staff 
Villa managers in a large 
institution for people with 
intellectual disabilities 
identified residents who 
had been administered 
INM. Also parents of 
children (not necessarily 
with intellectual 
disabilities) who had been 
ordered INM to manage 
prolonged seizures;  
education & support staff 
trained to administer INM 
to those children.   
80 people with 
intellectual 












between 23 & 74 
years who 
received INM 
% responses to 
survey items 
Seizures were controlled in 125 of these 131 people (95.4%), increasing to 
127 (96.9%) when a higher dose based on weight was administered.  There 
was only one minor adverse event.  Whilst not necessarily parents of 
children with intellectual disabilities, parents expressed a preference for INM 
over rectal diazepam because of the shorter time it took to take effect & wear 










Outcomes of community 
placement assessed.  
Involved visits from 
neurologist to oversee 
medication changes, 
education of home staff & 
emergency room 
physicians, & early 
intervention for seizures 
15 men & women 
relocated from institution 
to community home 
15 7 women & 8 
















Simplification of anticonvulsants, early intervention for seizures, & improved 
staff education resulted in fewer seizures, decreases in emergency room 
visits for status seizures & drug-related side effects, & increased levels of 
functioning as measured by activities of daily living. None of the individuals 
returned to the institution, & only 1 was relocated to a more structured living 
situation after several hospitalizations for pneumonia. 
Markar et al 
1998 
England Communication 










Audit including survey of 
GPs regarding 
satisfaction with service 
provided by CTLD 
57 GPs in one area (all 





by CTLD in one 
area 
% responses to 
survey items 
83.3% expressed overall satisfaction with the service. The remaining 16.6% 
made comments regarding the improvement of the service which include the 
comment that psychiatrists should take over the management of epilepsy in 
these patients 













information collected by 
interview with carer 
40 general practices 58 with 
epilepsy from 
total of 318 
Adult, mean age 
39.6 (SD 13.3) 





40 out of 55 participants (72.7%) had been referred to a specialist, two (5%) 
to a neurologist, 13 (32.5%) to an epilepsy clinic, 23 (57.5%) to a learning 
disability psychiatrist & two (5%) to another specialist.  Medication details 
were available for 57 participants: three (5.3%) were prescribed no AED, & 
aside from prescriptions for pro re nata (PRN) medication, 24 (42.1%) were 
prescribed a single AED, 23 (40.4%) were prescribed two AEDs, 5 (8.8%) 
three & 2 (3.5%) four.The most common AEDs were carbamazepine (n = 29, 
prescribed to 53.7% of those receiving medication), sodium valproate (n = 
26, 48.1%) & lamotrigine (n = 15, 27.8%). Phenytoin, primidone & one or 
other of the benzodiazepines were each prescribed to five participants 









Data on epilepsy were 
drawn from the first wave 
of data collected as part 
of the Intellectual 
Disability Supplement to 
the Irish Longitudinal 
Study on Ageing (IDS-
TILDA). 





epilepsy in total 
sample of 753 




% responses to 
survey items 
Epilepsy review: within past 12 months 80.8%; past 2 years 5.1%; over 2 
years ago 11.6%; never 2.5%.   Review by: GP 51%; psychiatrist 40%; 
neurologist 42%; more than one group/professional 34.7%. The majority of 
respondents (83.1%) kept a record of their seizures, with those living in 
residential care (92.7%) more likely to have such a record than those living 
independently (43.5%) or in the community (77.8%).   89.5% (n=205) were 
taking AEDs.  Of the 24 not taking AEDs, nine (37.5%) had not had a seizure 
in the past 2 years, three (12.5%) had had a seizure more than once a 
month, & three (12.5%) had had a seizure less than once a month but within 
the past 2 years, 9 (37.5%) did not answer the question on seizure 
frequency. 
Mobbs et al 
2002 






194 Managers of CNLDs 
working in 170 NHS 
Trusts 






in NHS  
% responses to 
survey items 
25 (23%) had CNLDs specializing in epilepsy.  CNLDs were offering training 
in services outside the NHS trust, such as social services & the 
independent/voluntary sectors in relation to epilepsy in 126 trusts (95%)  
Morgan et al 
2003 
Wales Health service 
use  
District-wide registers for 
epilepsy & intellectual 
disabilities created using 
record-linkage techniques 
Social services register, 
inpatient & outpatient 
databases, ‘mental 
handicap’ hospital dataset 
257 with 
epilepsy out of 
1595 
Mainly age 16+ 
in contact with 





Patients with intellectual disability & epilepsy from the institutional group 
were less likely to be admitted as inpatients compared with those in the 
community group (SAR 0.63 (95% CI 0.54, 0.73)). This was also true for 
admissions primarily for seizure (SAR 0.31 (95% CI 0.21, 0.40)).  Patients 
with intellectual disability & epilepsy from the institutional group were less 
likely to be seen as outpatients compared with those in the community group 
(SAR  0.19 (95% CI 0.15, 0.22).  For A&E admissions for those 
institutionalized individuals with co-existing epilepsy & intellectual disability, 
the standardized admission ratio was 0.34 (95% CI 0.23, 0.44) relative to the 
community based population. 










England Carers views on 
the use of rescue 
medication  
Postal survey (classed as 
service evaluation)  
People with intellectual 
disabilities & epilepsy 
identified from lists of two 
specialist intellectual 
disability services in 
Essex.  Questionnaires to 
care home managers, 
care staff or relatives.   




102 care staff 
responded.  15 





staff or relatives 




% responses to 
survey items 
Of 140 people with epilepsy, 84 (60%) had a care plan for epilepsy.  23 
carers had used rescue medication in the last year, 61% used buccal 
midazolam (BM), 26% rectal diazepam (RD) & 13% both.  17 episodes of RD 
use were recorded in the past year, compared to 46 episodes of BM use.  
Carers perceived BM to be more socially acceptable compared to RD.  It was 
rated as better across a range of parameters: convenience of administration, 
invasiveness of procedure, gender issues, social acceptability, consent 
issues, & onset of action.   When those who had used both BM & RD were 
asked which they preferred, of 27 carers who responded 26 preferred BM.     
Peeters 
2000 







Prospective analysis of 
decision tree over 16 
months compared to 6 
months retrospective 
review.  Non-medically 
trained staff instructed on 
proper identification of 
epileptic seizures; verbal 
& written instructions on 
antiepileptic treatment 
provided.  Initiation of 
AED treatment 5 or 7 
minutes after seizure 
onset indicated in the 
tree. 
Two establishments, both 
non-hospital settings  
20 At least 18 years 
of age, moderate 
to profound 
intellectual 
disabilities & had 
been receiving 
maintenance 
therapy with oral 
AEDs. 







Treatment of seizures as medical emergencies reduced frequency, duration, 
& severity (in comparison with results from the retrospective review). In 
patients who had cluster seizures with loss of consciousness, treatment with 
rectal diazepam or lorazepam resulted in good recovery of consciousness 
between intervals. In seizures involving a loss of consciousness, none lasted 
longer than 10 minutes, whereas in the 10 months prior to implementation of 
the decision tree, these types of seizures lasted for 20 minutes or more. For 
seizures without a loss of consciousness, none lasted longer than 37 
minutes. No patient was hospitalized.  Seizures lasted up to 18 hours in the 
retrospective review. 







interviews & qualitative 
analysis 
Convenience sample of 
mothers of adults with 
intellectual disabilities  
reflecting familiarity with 
specialist community 
based learning disability 
services (n=8) & 
mainstream hospital 
neurology services (n=9), 
& where both services 
were involved but neither 
appeared to have overall 
clinical responsibility (n=4) 












model of the 
role of parent-
proxies in the 
management 




Mothers were willing to live with what they considered to be an acceptable 
level of seizure activity, considered as a state of equipoise, & to reject 
possible changes in their son or daughter’s treatment. Clinicians may avoid 
going against mother’s wishes.  There was no evidence to indicate that 
clinicians were following the Convention on the Rights of Disabled Persons 
(CRPD) or Mental Capacity Act (MCA) & involving these adult patients in 
decisions about their own treatment.  




Author Country Focus Design Sample source Sample Size Sample features Outcome 
measures 
Results 
Reuber et al 
2008 
England Health service 




Sent to carers of all 442 
individuals from the 
Sheffield Case Register 
who also had a recorded 







said they did 
not have 
epilepsy 
Mean age 43.5 
(SD 16.1, range 
18—86 years), 
53.3% male, 
44.6% lived in 
residential care 
or supported 
living, 43.2% with 
carers, 6.9% on 
their own, 1.2% 
married or living 
with a partner,  
unknown 4.2%.  
% accessing 
health services 
22.7% had been free of seizures for over 1 year.  15.6% attended A&E at 
least once or in preceding year because seizures would not stop, 5.3% 
attended more often.   27.6% had a supply of RD or BM or both at home for 
prolonged seizures (27.4% RD, 4.5% BM), of whom 42.6% stated that they 
had received training from a nurse or a doctor on how to give the medication. 
40% of those who had been to A&E over the last year with a prolonged 
seizure had access to emergency medication.   One in 10 patients under 
primary care review was taking one of the ‘‘newer’’ AEDs.   53.3% of 
epilepsy diagnoses made by a seizure expert (neurologist or paediatrician). 
46.2% had had an EEG, & 41.3% a brain scan. 68.9% had been assessed 
by an expert in secondary care (neurologist, psychiatrist or epilepsy nurse) at 
some point. 60.4% had seen a neurologist, 34.2% an epilepsy nurse, & 
20.9% a psychiatrist. 70.7% had an epilepsy treatment review within the last 
12 months, the rest less frequently.  38.7% were under review in secondary 
care (neurologist, psychiatrist or epilepsy nurse), 52.9% were under review in 
primary care alone, & 8.9% epilepsy treatment had not been reviewed at all.   
Patients with more severe epilepsy more likely to be under specialist care but 
60.6% of patients with ongoing seizures,  57.9% with major seizures & 
68.7% of individuals taken to hospital with prolonged seizures had no access 
to specialist advice. 






observational study; data 
from clinical notes 
(preceding 3 months) & 
interviews with carers, 
learning disability team 
members, any neurology-
based clinicians involved 
in their management & 
GP 
All those with intellectual 
disability & epilepsy in 5 
community learning 
disability services that 
covered one county 
(excluding those without 
capacity to consent); 71% 
of those identified took 
part 
183 Mean age 40 
years, range 16–
72 years; 55%  




severe, & 7% 
profound. 43% 
diagnosed with 
epilepsy for at 










37% received epilepsy care from a hospital-based neurology service. The 
patients’ GP also actively contributed in terms of initiating or changing 
treatments in 63% of cases & for 6% of participants the GP was the only 
clinician supporting epilepsy treatment.  Around a third were receiving 
epilepsy management from hospital-based neurology services but it was not 
clear what factors determined which treatment pathway patients followed.   
1% were not taking any AEDs, 40% were receiving monotherapy, 36% were 
being treated with two AEDs & 23% were prescribed three or more AEDs.  
There was a significant difference between the mean number of AEDs 
prescribed to those whose epilepsy was only managed by learning disability 
services (1.7 AEDs) & those who also received neurology service input (2.14 
AEDs) (t = 3.257, P = 0.001). Clobazam was prescribed relatively more 
frequently to those receiving neurology-based AED management (chi square 
6.627, df = 1, p = 0.018), whilst sodium valproate was prescribed relatively 
less often (chi square 5.027, df = 1, p = 0.025). Other AEDs were prescribed 
at approximately similar rates in learning disability & neurology services.   















(medical care & 
services) 
Online survey with open-
ended comments 
analysed qualitatively 
International online survey 
promoted by various 
epilepsy associations, 
support groups, & 
networks in 7 countries.  
Only responses from UK 
& Ireland used due to low 
numbers from other 
countries 
113 Family 38 (34%); 
paid carer 16 
(14%); 
professional  59 





Professionals & carers differ in their expectations of treatment & with regard 
to maximizing communication during consultations. Findings suggest that the 
potential of consultations to provide information for carers, as well as to allay 
concerns, may not be realized. Rescue medications were viewed favorably; 
however, respondents expressed less satisfaction with routine medications. 
These findings may reflect a failure by professionals to appropriately transfer 
knowledge of these treatments. 
Tiffin et al 
2001 
England AED use Audit based on case 
notes 
23 wards which housed 
adult in-patients with 
learning disabilities 
75 Mean age 38.6 











As a result of information obtained during the audit, one patient received a 
diagnosis of factitious epilepsy & his treatment was subsequently withdrawn. 
All patients with a history of status epilepticus were prescribed RD or, more 
rarely, INM.   44% were on monotherapy, 40% on 2 AEDs, 13.3% on 3 
AEDs, & 2.7% on 4 AEDs.   13 (17%) were identified as potentially benefiting 
from a reduction in the number of AEDs they were prescribed. 15 other 
patients were currently having a trial AED reduction.  Only around 24% of 
patients with partial seizures received an MRI or CT scan although this may 
be due to sound practical reasons.  11 (14.7%) had received CT scans of the 
head with 2 having had failed attempts due to poor co-operation. 6 had 
received MRIs and one had a failed attempt at an MRI scan due to poor 
cooperation.  The average number of standard EEGs performed was 3 per 








research.  Data gathered 
continuously over a 22-
month period in 2004–
2006 by interviews, 
observation, written 
reports of meetings & 
personal stories  
Two residential units of an 
epilepsy centre.  Only 
nursing team members 
(registered nurses & 
nursing assistant staff) 
fully participated in the 
action research groups 
Nursing team 
members for 2 
units each with 
12 clients 
Registered 





During the action research, caregiving became more client-centred, & the 
insight that clients should be involved in decision-making grew.  Assessment 
of client risk became more systematic & ‘steps to an individual framework for 
decision-making’ were developed as a tool for a systematic approach.  













Qualitative method of 
multiple embedded case 
study.  Based on 
interviews with client’s 
parent, brother or sister; 
the care-manager, who 
was the physician or 
psychologist responsible 
for management of the 
client’s care; the nurse, 
who provided the care & 
the client when this was 













Measures were taken on an individual basis & included (poly)pharmacy, 
supervision, avoidance of higher risk activities, provision of protective 
clothing, or physical restraint of movement. General measures were taken in 
the furnishing of rooms (eg induction cooking equipment with no hot 
surfaces).    Protective measures were often taken in situations of immediate 
threat, allowing no time to consider their negative effects.  Continuous 
anxiety about the possibility of seizure & injury caused constant vigilance in 
parents & nurses. Systematic recording & analysis of accidents was lacking 
in all of the cases, making it hard for those involved to examine to what 
extent their fear was proportionate to the risk.   
Whitten et al 
2007 
England Introduction of a 
specialist multi-
disciplinary 
epilepsy clinic in 
line with NICE 
guidelines 
Audit prior to & following 
implementation of 
epilepsy clinic (previously 
seen at a learning 
disability mental health 
outpatient clinic); based 
on clinical notes 
Patients with diagnosis of 
epilepsy within one 
consultant's catchment 
area of the learning 
disability service 
23 All with diagnosis 
of epilepsy in 
catchment area 
% meeting 
items in audit 
tool 
83% compared to 6% of patients had accurate name & detailed seizure 
descriptions. 100% compared to 81% & 57% had recording of seizure 
frequency & severity. 76% of patients had changes made to their seizure 
diagnosis. 91% compared to 50% of consultations led to changes in 
treatment plans. 96% compared to 64% had medication prescribed relevant 
to their seizure type. All patients prescribed 3 or more AED’s received a 
medication reduction plan. All patients received an individualised risk 
assessment compared to 4.5% beforehand & 68% had risks identified.   The 
implementation of NICE guidelines in this study showed improvements to 
seizure assessments, matching of medication to seizure type, patient care & 
epilepsy management. 
Intellectual disabilities & epilepsy 
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